36 results
Page 2 of 2
10-KT
qpfxfa7 dg7foth7zm7
26 Mar 18
Annual report (with FYE transition)
12:00am
8-K
EX-10.1
rusfhy6z
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
rxjri0a45wzkz
27 Oct 14
Definitive proxy
12:00am
PRER14A
e0b vjuz8uub1uj6po
23 Oct 14
Preliminary revised proxy
12:00am
8-K
EX-10.1
mj3bz7oj
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
oamw7m56piq i0
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
10-12G/A
EX-99.1
33rd33vr 9xnd2o3pbx
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
m5ggf0 8c
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
8oj3ks5v3
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
alh10v 30tukf
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-99.1
1i5c9pifb
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.2
7gyiyelzdgvw7i
8 Aug 13
Registration of securities
12:00am